Skip to main content
PMC home page
Gut logoLink to Gut
. 1979 Oct;20(10):868–874. doi: 10.1136/gut.20.10.868

Survival and the immune response in patients with carcinoma of the colorectum.

A K House, A G Watt
PMCID: PMC1412722  PMID: 533699

Abstract

One hundred and seven patients with colorectal carcinoma were examined for their immune response to autologous tumour. Patient leucocyte migration inhibition by tumour antigen, migration inhibition of normal subject's leucocytes by patient's serum, and the assessment of lymphocyte invasion of the tumour specimen were used to measure the immune response. Forty-one and 51% of patients were immune by leucocyte migration inhibition and tumour invasion by lymphocytes respectively. The immune patients had a survival advantage at three years on Chi-squared analysis. Patients whose serum contained a factor that inhibited the migration of leucocytes obtained from normal individuals had a diminished survival prognosis. The donors of these sera had a 50% chance of dying or of developing recurrent disease. These same individuals represented 30% of all those tested by this method. The immune patients included the sera donors as a subgroup 30% of all those tested by this method. The immune patients included the sera donors as a subgroup who, if excluded from the life table analysis, left a group of immune subjects who had very superior survival features.

Full text

PDF
868

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anastassiades O. T., Pryce D. M. Immunological significance of the morphological changes in lymph nodes draining breast cancer. Br J Cancer. 1966 Jun;20(2):239–249. doi: 10.1038/bjc.1966.30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Black M. M., Freeman C., Mork T., Harvei S., Cutler S. J. Prognostic significance of microscopic structure of gastric carcinomas and their regional lymph nodes. Cancer. 1971 Mar;27(3):703–711. doi: 10.1002/1097-0142(197103)27:3<703::aid-cncr2820270329>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  3. Cochran A. J., Mackie R. M., Ross C. E., Ogg L. J., Jackson A. M. Leukocyte migration inhibition by cancer patients' sera. Int J Cancer. 1976 Sep 15;18(3):274–281. doi: 10.1002/ijc.2910180303. [DOI] [PubMed] [Google Scholar]
  4. Cochrum K. C., Salvatierra O., Cullen B. L., Perkins H. A., Hanes D. M., Fudenberg H. H. Leukocyte migration inhibitory factor (LIF) as an indicator of mixed lymphocyte culture (MLC) reactivity. Transplant Proc. 1977 Mar;9(1):97–101. [PubMed] [Google Scholar]
  5. Elias E. G., Elias L. L. Autogenous leukocyte migration in human malignancies. Cancer. 1975 Oct;36(4):1393–1398. doi: 10.1002/1097-0142(197510)36:4<1393::aid-cncr2820360431>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  6. Elias E. G., Elias L. L., Didolkar M. S., Hebel J. R. Cellular immunity in patients with colorectal adenocarcinoma measured by autologous leukocyte migration inhibition. Cancer. 1977 Aug;40(2):687–692. doi: 10.1002/1097-0142(197708)40:2<687::aid-cncr2820400215>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  7. Fimmel P. J. Studies on leukocyte migration inhibiton: the role of E rosette-forming cells in specific antigen-induced inhibition of migration. J Immunol. 1975 Jul;115(1):135–138. [PubMed] [Google Scholar]
  8. Gill P. G., Morris P. J. The survival of patients with colorectal cancer treated in a regional hospital. Br J Surg. 1978 Jan;65(1):17–20. doi: 10.1002/bjs.1800650105. [DOI] [PubMed] [Google Scholar]
  9. Grinnell R. S. THE GRADING AND PROGNOSIS OF CARCINOMA OF THE COLON AND RECTUM. Ann Surg. 1939 Apr;109(4):500–533. doi: 10.1097/00000658-193904000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Guillou P. J., Giles G. R. Inhibition of leucocyte migration by tumour-associated antigens of the colon and rectum. Gut. 1973 Sep;14(9):733–738. doi: 10.1136/gut.14.9.733. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Górski A. J. Superiority of corpuscular BCG to soluble PPD antigen in the leucocyte migration assay. Clin Exp Immunol. 1974 Sep;18(1):149–153. [PMC free article] [PubMed] [Google Scholar]
  12. Hoffken K., Meredith I. D., Robins R. A., Baldwin R. W., Davies C. J., Blamey R. W. Circulating immune complexes in patients with breast cancer. Br Med J. 1977 Jul 23;2(6081):218–220. doi: 10.1136/bmj.2.6081.218. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. House A. K., Wisniewski S., Woodings T. L. Immunity in colonic tumor patients after operation: determination by leukocyte-migration inhibition. Dis Colon Rectum. 1975 Mar;18(2):100–106. doi: 10.1007/BF02587153. [DOI] [PubMed] [Google Scholar]
  14. Imai K., Hosokawa Y., Abe H., Yachi A., Wada T. Inhibition of leucocyte migration by potassium chloride extracts of human tumor cells in ascites and from tissues. Gan. 1977 Oct;68(5):581–587. [PubMed] [Google Scholar]
  15. Jubert A. V., Talbott T. M., Mazier W. P., MacKeigan J. M., Campos M. M., Benjamin H. G., Muldoon J. P., Ferguson J. A., Maycroft T. M., Bowman H. E. Correlation of immune responses with Dukes classification in colorectal carcinoma. Surgery. 1977 Oct;82(4):452–459. [PubMed] [Google Scholar]
  16. Montessori G. A., Donald J. C. Invasion profile of colorectal carcinoma. Dis Colon Rectum. 1978 Jan-Feb;21(1):26–28. doi: 10.1007/BF02586542. [DOI] [PubMed] [Google Scholar]
  17. Murray D., Hreno A., Dutton J., Hampson L. G. Prognosis in colon cancer: a pathologic reassessment. Arch Surg. 1975 Aug;110(8):908–913. doi: 10.1001/archsurg.1975.01360140052011. [DOI] [PubMed] [Google Scholar]
  18. Rao B., Wanebo H. J., Pinsky C., Stearns M., Jr, Oettgen H. F. Delayed hypersensitivity reactions in patients with carcinoma of the colon and rectum. Surg Gynecol Obstet. 1977 May;144(5):677–681. [PubMed] [Google Scholar]
  19. Slaney G. Results of treatment of carcinoma of the colon and rectum. Mod Trends Surg. 1971;3:69–89. [PubMed] [Google Scholar]
  20. Soborg M., Bendixen G. Human lymphocyte migration as a parameter of hypersensitivity. Acta Med Scand. 1967 Feb;181(2):247–256. doi: 10.1111/j.0954-6820.1967.tb07255.x. [DOI] [PubMed] [Google Scholar]
  21. Stein J. A., Adler A., Efraim S. B., Maor M. Immunocompetence, immunosuppression, and human breast cancer. I. An analysis of their relationship by known parameters of cell-mediated immunity in well-defined clinical stages of disease. Cancer. 1976 Sep;38(3):1171–1187. doi: 10.1002/1097-0142(197609)38:3<1171::aid-cncr2820380319>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  22. Watt A. G., House A. K. Colonic carcinoma: a quantitative assessment of lymphocyte infiltration at the periphery of colonic tumors related to prognosis. Cancer. 1978 Jan;41(1):279–282. doi: 10.1002/1097-0142(197801)41:1<279::aid-cncr2820410139>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  23. Whittaker M. G., Rees K., Clark C. G. Reduced lymphocyte transformation in breast cancer. Lancet. 1971 May 1;1(7705):892–893. doi: 10.1016/s0140-6736(71)92448-2. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES